Although epidemiological data on heart failure (HF) with preserved ejection fraction (HFpEF)
are scarce in the Middle East, North Africa and Turkey (MENAT) region, Lancet Global …

It is estimated that by 2050, 17% of the world's population will be greater than 85 years old,
which, combined with cardiovascular disease (CVD) being the leading cause of death and …

INTROduCTION There is still little information regarding a detailed description and
predictors of different subtypes of heart failure (HF) in the Polish population. ObjECTIvEs …

Background Heart failure (HF) is a serious and advanced stage of various cardiac diseases
with high mortality and rehospitalization rates. Phosphoglycerate mutase 2 (PGAM2) …

Heart failure (HF) with preserved ejection fraction (HFpEF) is a clinical syndrome
characterized by signs and symptoms of HF in the presence of a normal left ventricular …

Heart failure is a clinical condition in which the heart is unable to maintain adequate cardiac
output. Liraglutide is a glucagon-like peptide 1 (GLP-1) analogue that is used for the …

Background During the last few years, increasing focus has been placed on heart failure
with mildly reduced ejection fraction (HFmrEF), an intermediate phenotype from preserved to …

Cardiovascular diseases are the leading cause of death worldwide. Therefore, this study
aims to develop a mobile application utilizing the Internet of Things (IoT) to monitor patients' …

Background An increasing number of lung cancer patients are opting for lobectomy for
oncological treatment. However, due to the unique organismal condition of elderly patients …

Cardiovascular diseases are the leading cause of death worldwide. Therefore, this study
aims to develop a mobile application utilizing the Internet of Things (IoT) to monitor patients' …